Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kinase data mining: dealing with the information (over-)flow

Knut Eis1, Stuart J Ince, Carsten Jahn

  • 1Medicinal Chemistry, Research Center Europe, Schering AG, Corporate Research, 13342 Berlin, Germany. knut.eis@schering.de

Chembiochem : a European Journal of Chemical Biology
|February 16, 2005
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung Cancer.

Cancer discovery·2025
Same author

Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signaling.

Cell chemical biology·2024
Same author

Cellenium-a scalable and interactive visual analytics app for exploring multimodal single-cell data.

Bioinformatics (Oxford, England)·2023
Same author

New Generation of sGC Stimulators: Discovery of Imidazo[1,2-<i>a</i>]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension.

Journal of medicinal chemistry·2023
Same author

Correction to "Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists BAY-4931 and BAY-0069".

Journal of medicinal chemistry·2022
Same author

Discovery and characterization of orally bioavailable 4-chloro-6-fluoroisophthalamides as covalent PPARG inverse-agonists.

Bioorganic & medicinal chemistry·2022